France unquote
Revaia aims for EUR 400m - EUR 500m final close for Fund II by year-end
VC firm’s second fund is expected to be up to double the size of its EUR 250m debut vehicle
Bridgepoint acquisition of Dentego collapses
GP had entered into exclusive negotiations with vendor G Square following a Lazard-led process
Squire Patton Boggs hires senior partner to Paris office
Maxime Dequesne’s appointment will enhance the law firm’s private equity practice in France
Raise heads for second close for debut impact VC fund
French sponsor seeks to attract state-backed LPs for new strategy targeting ESG-focused startups
Cathay Capital launches EUR 500m health fund
New vehicle will invest at the crossover of health care, life sciences and tech with EUR 5m-50m tickets
Montagu launches Arkopharma sale; attracts PE and trade buyers
Bridgepoint and CVC’s Cooper among parties interested in the natural medicines and food supplements maker
BC Partners, Ardian among sponsors in second round of Simago sale
Antin and Eurazeo also in race for minority stake in the French medical imaging specialist
Eurazeo heads for EUR 1bn H1 2022 close for PME IV
GP also said in its Q1 2022 results that it has EUR 4.7bn in dry powder across its strategies
BC Partners, Cinven, Apax and Wendel circle Havea sale
French natural consumer healthcare manufacturer is set to collect non-binding bids next month
EMZ in final stretch of EUR 1.2bn EMZ 10 fundraise
EMZ 10 held a first close in excess of EUR 800m earlier in May and continues to seek new LPs
French sponsor-led deal flow pushes through despite war in Ukraine stalling some auctions
YTD sponsor-led transactions value have so far seen the second highest performing year since 2015
Apollo buys minority stake in life sciences investor Sofinnova
Deal gives the French VC firm EUR 1bn in commitments for future funds as well as access to broader LP base
Andera Partners holds EUR 450m first close for Andera MidCap 5
Vehicle has a target of EUR 600m and is around 50% larger than its predecessor, Winch Capital 4
VC Profile: Jeito Capital in final stretch of biotech fund deployment
Founder Rafaèle Tordjman outlines the French sponsor’s strategy as it aims to remain independent amid wave of consolidation in healthcare funds
Naxicap preps for Fund III with eyes set on DACH, Benelux expansion
Sponsor expected to hit the road “soon” for its new EUR 1bn-plus small mid-cap buyout fund
Eurazeo gears up for Eurazeo Capital V
GP has registered the fund almost three years after the EUR 2.5bn final close of its predecessor
Astorg adds new partner to Paris office
With addition of Jean Raby, Astorg will establish two new functions
Payot sale interrupted as Weinberg drops out
LBO France-backed French skincare company’s exposure to the Russian market was major issue raise by bidder
Teachers' Venture Growth leads Alan's EUR 183m Series E
Temasek, Index, Coatue, Ribbit Capital, Exor, Dragoneer, and Lakestar also joined the round which values Alan at EUR 2.7bn
Latour sells Atlas For Men to Motion Equity
Vendor owned the French menswear retailer for just three years; buyer participated in 2019 auction
LGT sells Batisanté to IK Partners
New owner investing via Fund IX; looks to grow the company organically
IK pre-empts Batisanté sale at the start of second round
LGT-owned building hygiene and safety specialist attracted interest from several other financial sponsors
Tilt Capital holds first close for debut energy transition fund
Co-founder Nicolas Piau speaks to Unquote about the GP's Siparex partnership. fundraise and strategy
Qualium III expects autumn final close
Vehicle will follow the investment strategy of its predecessor and has a EUR 500m target